![Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial - The Lancet Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial - The Lancet](https://www.thelancet.com/cms/attachment/ca686eb6-dd86-498c-931a-56171cd77e76/gr1_lrg.gif)
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial - The Lancet
![Associations of hyperosmolar medications administered via nasogastric or nasoduodenal tubes and feeding adequacy, food intolerance and gastrointestinal complications amongst critically ill patients: A retrospective study - Clinical Nutrition ESPEN Associations of hyperosmolar medications administered via nasogastric or nasoduodenal tubes and feeding adequacy, food intolerance and gastrointestinal complications amongst critically ill patients: A retrospective study - Clinical Nutrition ESPEN](https://clinicalnutritionespen.com/cms/attachment/739f8cd2-71c2-4f1c-b7f6-39102f1365bc/gr1.jpg)
Associations of hyperosmolar medications administered via nasogastric or nasoduodenal tubes and feeding adequacy, food intolerance and gastrointestinal complications amongst critically ill patients: A retrospective study - Clinical Nutrition ESPEN
![Enteral Nutrition Administration Record Prescribing Process Using Computerized Order Entry: A New Paradigm and Opportunities to Improve Outcomes in Critically Ill Patients - Kamel - 2021 - Journal of Parenteral and Enteral Enteral Nutrition Administration Record Prescribing Process Using Computerized Order Entry: A New Paradigm and Opportunities to Improve Outcomes in Critically Ill Patients - Kamel - 2021 - Journal of Parenteral and Enteral](https://aspenjournals.onlinelibrary.wiley.com/cms/asset/ba5576e5-196b-4ef6-98d5-89e5afa40c2e/jpen1870-fig-0003-m.jpg)
Enteral Nutrition Administration Record Prescribing Process Using Computerized Order Entry: A New Paradigm and Opportunities to Improve Outcomes in Critically Ill Patients - Kamel - 2021 - Journal of Parenteral and Enteral
![Abbott Nutrition Oxepa Nutritional Supplement, R, L62717, 1 Pound : Amazon.com.mx: Salud y Cuidado Personal Abbott Nutrition Oxepa Nutritional Supplement, R, L62717, 1 Pound : Amazon.com.mx: Salud y Cuidado Personal](https://m.media-amazon.com/images/I/71N5ym9cYbL._AC_UF1000,1000_QL80_.jpg)